Beattie, J., Al-Khafaji, H.
, Noer, P. R., Alkharobi, H. E., Alhodhodi, A., Meade, J., El-Gendy, R.
& Oxvig, C. (2018).
Insulin- like growth factor-binding protein action in bone tissue: A key role for pregnancy- associated plasma protein-A.
Frontiers in Endocrinology,
9, Artikel 31.
https://doi.org/10.3389/fendo.2018.00031Espelund, U., Renehan, A. G., Cold, S.
, Oxvig, C., Lancashire, L., Su, Z.
, Flyvbjerg, A. & Frystyk, J. (2018).
Prognostic relevance and performance characteristics of serum IGFBP-2 and PAPP-A in women with breast cancer: a long-term Danish cohort study.
Cancer Medicine,
7(6), 2391-2404.
https://doi.org/10.1002/cam4.1504
Cediel, G., Rueda, F.
, Oxvig, C., Oliveras, T., Labata, C., de Diego, O., Ferrer, M., Aranda-Nevado, M. C., Serra-Gregori, J., Núñez, J., García, C. & Bayes-Genis, A. (2018).
Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction.
Cardiovascular Diabetology,
17, Artikel 63.
https://doi.org/10.1186/s12933-018-0710-3Smith, Y. E., Toomey, S., Napoletano, S., Kirwan, G., Schadow, C., Chubb, A. J.
, Mikkelsen, J. H., Oxvig, C. & Harmey, J. H. (2018).
Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.
BMC Cancer,
18, Artikel 1016.
https://doi.org/10.1186/s12885-018-4950-0Yan, X., Wang, Z., Westberg-Rasmussen, S., Tarbier, M., Rathjen, T., Tattikota, S. G., Peck, B. C. E., Kanke, M.
, Oxvig, C., Frystyk, J., Starup-Linde, J., Sethupathy, P., Friedländer, M. R.
, Gregersen, S. & Poy, M. N. (2017).
Differential impact of glucose administered intravenously and orally on circulating miR-375 levels in human subjects.
Journal of Clinical Endocrinology and Metabolism,
102(10), 3749-3755.
https://doi.org/10.1210/jc.2017-01365
